PGMN3 Share Price Performance
R$5.79
2.54 (78.15%)
26.3% undervalued intrinsic discount
R$7.86
Fair Value
Price R$5.79
AnalystConsensusTarget R$7.86
AnalystHighTarget R$10.00
AnalystLowTarget R$5.00
Fair ValueR$7.86
Share Pricen/a
Empreendimentos Pague Menos S.A. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
PGMN3 Community Narratives
AN
Fair Value R$7.86 26.3% undervalued intrinsic discount
Pharmaceutical Retail And Digital Channels Will Expand Market Reach
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value R$10 42.1% undervalued intrinsic discount
Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value R$5 15.8% overvalued intrinsic discount
Brazil Retail Will Falter Amid Digital Competition
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Pharmaceutical Retail And Digital Channels Will Expand Market Reach
Key Takeaways Expanding pharmacy offerings, urbanization, and robust digital growth are driving sustained revenue increases, market expansion, and higher-value customer engagement. Operational efficiencies and industry trends are boosting earnings, margins, and positioning for greater market share and long-term profitability.Read more
30
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
R$7.86
26.3% undervalued intrinsic discount
Fair Value
Revenue
15.27% p.a.
Profit Margin
2.11%
Future PE
22.65x
Price in 2029
R$13.63
Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion
Key Takeaways Rapid store integration, digital channel growth, and operational leverage position the company for significant revenue and margin expansion, outpacing analyst expectations. Strong chronic care focus, demographic tailwinds, and local market consolidation drive long-term sales growth, top-line diversification, and industry-leading scale advantages.Read more
7
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
R$10
42.1% undervalued intrinsic discount
Fair Value
Revenue
19.44% p.a.
Profit Margin
1.96%
Future PE
27.85x
Price in 2029
R$17.31
Brazil Retail Will Falter Amid Digital Competition
Key Takeaways Growing digital health adoption and demographic shifts threaten store volumes, limiting revenue growth and the effectiveness of physical expansion strategies. Intensified competition and rising regulatory burdens risk squeezing margins, increasing operational costs, and dampening overall profitability.Read more
19
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
R$5
15.8% overvalued intrinsic discount
Fair Value
Revenue
7.78% p.a.
Profit Margin
2.2%
Future PE
17.89x
Price in 2029
R$8.78
Trending Discussion
Recently Updated Narratives
AN
PGMN3: Follow On Offering And Steady Assumptions Will Support Future Upside
Fair Value: R$7.86 26.3% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
PGMN3: Follow On Offering At R$6.55 Will Support Further Upside Potential
Fair Value: R$10 42.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
PGMN3: Richer P/E And Weaker Margin Assumptions Will Pressure Returns
Fair Value: R$5 15.8% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Empreendimentos Pague Menos S.A. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 04, 2026
- 0.39
- 31.95%
- 1.75%
- 56.0%
About PGMN3
- Founded
- 1981
- Employees
- 28207
- CEO
- WebsiteView website
Empreendimentos Pague Menos S.A. engages in the retail sale of medicines, perfumeries, and personal hygiene and beauty products in Brazil. The company offers medicines and health care products; personal hygiene products, including deodorant, intimate care, and oral hygiene; foot, hair, face, and hand care products; dermo and beauty products; and repellent, diaper, cloth, and food products, as well as other accessories for moms and babies. The company also offers vaccines, clinical analysis tests, and basic health services; clothing and accessories, supplements, first aid, food and drinks, chocolates, ice creams, popsicles, toys, pet and home products, laptop accessories, utilities, and others; and cereals, fibers, vitamins and minerals, first aid, and herbal medicines and natural products. It sells its products through retail stores and online. Empreendimentos Pague Menos S.A. was incorporated in 1981 and is based in Fortaleza, Brazil.
